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Background: This study provides a vital insight in assessing the clinical and biochemical changes in interleukin
(IL)-1β levels in peri-miniscrew crevicular fluid (PMCF) during the course of orthodontic tooth movement.
Methods: The study comprised the analysis of IL-1β in peri-miniscrew crevicular fluid obtained from crevices
around the miniscrews inserted in 11 patients (eight females and three males, mean age 17.3 ± 4.64 years) with all
first premolar extraction and maximum anchorage requirement using miniscrew-supported anchorage. Miniscrews
were loaded at 3 weeks after placement by 200-g nitinol closed coil springs of 9-mm length for en masse retraction.
Peri-miniscrew crevicular fluid was collected at miniscrew placement (T1), at 3 weeks (T2/baseline) and on loading
at 0 (T3) and 1 day (T4), 21 (T5), 72 (T6), 120 (T7), 180 (T8) and 300 (T9) days. IL-1β levels were estimated by
enzyme-linked immunosorbent assay (ELISA). Peri-miniscrew tissue was examined for signs of inflammation, and
also, miniscrew mobility was assessed with Periotest and handles of two mouth mirrors.
Results: IL-1β levels in all miniscrews were significantly higher at T1 and peaked again at T4 showing a bimodal
peak. However, there was a gradual and statistically significant decrease in IL-1β till T5, while further changes till the
end of the study were statistically not significant.
Conclusions: The changing levels of IL-1β levels in PMCF over a duration of 300 days are suggestive of the
underlying inflammatory process. IL-1β levels in PMCF show a significant rise during miniscrew insertion and on
immediate loading. The trend of gradually reducing IL-1β levels around the miniscrew over the period after loading
towards baseline is suggestive of adaptive bone response to stimulus.
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Miniscrews have drawn immense consideration in or-
thodontic armamentarium since they were initially used
as contrivance for reinforcing orthodontic anchorage.
These implements now stand poised to become one of
the most imperative and useful means of orthodontic
anchorage for eclectic clinical applications due to their
ease in placement at various locations in the mouth.
However, it is quite true that there is still some appre-
hension regarding their stability and hence usefulness in
providing absolute orthodontic anchorage during the en-
tire course of treatment.* Correspondence: opk15@hotmail.com
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in any medium, provided the original work is pThe reported success rate of the miniscrews ranged
from 71.4% to 100% [1,2]. Peri-implantitis accounts for
about 30% of miniscrew failures [3]. Peri-implantitis is a
progressive peri-implant bone loss in conjunction with
soft tissue inflammatory lesion. Initially, peri-mucositis
(a reversible inflammation of the soft tissues surround-
ing the miniscrew) occurs, which if left untreated may
progress to peri-implantitis [4]. An early and reliable de-
tection of any adverse peri-miniscrew tissue reaction is
essential for patients being treated with miniscrew [5].
Recent studies show that in periodontal and peri-
miniscrew tissues, cytokines, tumour necrosis factor and
transforming growth factor have important roles in re-
gulating and amplifying inflammatory response [5-7].
Interleukin (IL)-1β is one of the most potent cytokine in
the inflammatory process in the oral cavity triggered by
various stimuli including neurotransmitters, bacterialan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Assembly showing retraction mechanics using
miniscrew as anchorage.
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action of IL-1β includes attracting leucocytes and stimu-
lating fibroblasts, endothelial cells, osteoclasts and osteo-
blasts to promote bone resorption and to inhibit bone
formation [8].
Peri-miniscrew crevicular fluid (PMCF) is an osmotic-
ally mediated inflammatory exudate originating from the
vessels of the gingival plexus. Its composition is similar
to that of the gingival crevicular fluid (GCF) containing
host-derived enzymes and their inhibitors, inflammatory
mediators, host response modifiers and tissue breakdown
products [9]. Analysis of PMCF offers a non-invasive
means of studying host response in peri-miniscrew dis-
ease and may provide an early indication of patients at
risk for active disease [10].
There are several reports on IL-1β in dental implants;
however, IL-1β in PMCF around miniscrews has not
been explored enough. Sari and Ucar [7] studied the
level of IL-1β around miniscrews starting 2 weeks after
miniscrew placement and activation of coil spring, fol-
lowed up to 21 days. No study has been reported so far
about the changes in IL-1β levels at miniscrew place-
ment, before loading and after loading during the course
of extraction space closure. Therefore, this comprehen-
sive study was undertaken with the aim to evaluate the
changes in IL-1β levels in PMCF at miniscrew place-
ment, before and after application of orthodontic forces
and its correlation with the clinical parameters over the
course of orthodontic treatment.
Methods
PMCF analysis was conducted from samples collected
around the crevices of miniscrews placed in 11 bimaxil-
lary protrusive patients (mean age 17.3 ± 4.64 years) re-
quiring all first premolar extraction and treated with
Roth prescription (0.022″ × 0.028″). The patients were
followed for 300 days. In one of the patients, two minis-
crews failed 2 weeks after placement; hence, the patient
could not be followed throughout the period of the
study. Therefore, the study was conducted to follow a
total of 40 miniscrews in 10 patients for 300 days. Eth-
ical clearance was obtained from the Ethics Committee
of All India Institute of Medical Sciences, New Delhi
with letter reference number IESC/T-20/29.01.10 dated
8 March 2010 and letter reference number IESC/T-22/
2011 dated 13 January 2011. Written consent was ob-
tained from each patient prior to their inclusion in the
study. None of the patients had history of any syste-
mic disease, hormonal imbalance or drug intake, and all
had satisfactory periodontal health prior to the start of
orthodontic treatment.
The buccal interradicular bone in the attached gingiva
between the second premolar and first molar was chosen
as site for miniscrew placement. Miniscrews (8-mm long,1.5 mm in diameter, bracket head type; Absoanchor,
Dentos, Daegu, South Korea) were placed at the intended
sites at 60° to the long axis of the teeth under local anaes-
thesia [11]. Miniscrews were connected to the first mo-
lars using a 0.017″ × 0.025″ stainless steel wire passively,
thereby providing indirect anchorage. En masse retraction
was initiated 3 weeks after miniscrew insertion with a
9.0-mm nitinol closed coil spring (200-g force) attached to
the soldered hook in between the lateral incisor and ca-
nine in a 0.019″ × 0.025″ stainless steel wire in both the
arches. The retraction appliance was adjusted so as to
provide constant force till space closure was achieved.
However, the amount of force that was loaded to the
miniscrew head at T3 and continued up to T9 might
be different from 200-g because a sectional assembly
was connected between the implant head and accessory
buccal tube on the first molar (Figure 1).
The patients were instructed and followed for oral hy-
giene, more so around the peri-miniscrew with frequent
brushing using a soft brush and mouth rinsing with 0.5 oz
of 0.2% chlorhexidine gluconate twice daily. No anti-
inflammatory drug was prescribed prior to and after
miniscrew placement.
Schedule of sample collection and clinical examination
Each sample of PMCF was collected by a 1 to 5-μl cali-
brated volumetric micro-capillary pipette (Sigma Aldrich
Chemicals Company Limited, Bangalore, India) placed
at the crevice, according to the method described by
Griffiths [12]. The samples were collected at the following
time observations: T1 (4 h after miniscrew placement), T2
(baseline, 3 weeks just prior to loading) and on loading
T3 (0 day), T4 (1 day), T5 (21 days), T6 (72 days), T7
(120 days), T8 (180 days) and T9 (300 days) (Table 1). Al-
though PMCF sample T1 was taken 4 h after miniscrew
placement to allow cessation of bleeding, PMCF samples
Table 1 Schedule of PMCF sample collection and clinical
examination
Time Schedule of sample collection
Before loading T1 Miniscrew placement
T2 3 weeks prior to loading
After loading T3 Immediately after loading
T4 1 day after loading
T5 At 21 days
T6 At 72 days
T7 At 120 days
T8 At 180 days
T9 At 300 days
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miniscrew placement procedure at T1 were discarded.
Isolation of the miniscrew site was done with a cheek re-
tractor, cotton rolls and a gentle air spray. PMCF (1 μl)
was collected in Eppendorf tubes for 5 to 20 min from
each test site at 25°C. Implant placement and PMCF sam-
ple collection was done in the morning hours between
9 a.m. and 11 a.m. except for T1 which was collected
between 1 p.m. and 3 p.m. since it had to be collec-
ted 4 h after implant placement. GCF samples were
gently collected, and extreme care was taken not to
cause any slightest harm or injury during the sample
collection. The samples thus obtained were diluted to
1:100 with Sorensen's buffer (0.05% bovine serum albumin
in phosphate buffered saline, ph 7.0), centrifuged at
2,000 rpm for 1 min and stored at −70°C until assayed for
interleukin levels.
IL-1β levels were estimated using human IL-1β ELISA
kit Diaclone-Eli-pair (Besancon, France). Optical dens-
ity was measured at 450 nm using Omega Microplate
Reader™ (BMG Labtech, Ortenberg, Germany). The quan-
tification of IL-1β was determined using standard curves
for IL-1β, which showed a direct relationship between op-
tical density and cytokine concentration.
Presence of any signs of peri-miniscrew inflammation
(redness, swelling, pain) was detected clinically. Minis-
crew mobility was assessed by a single operator using
Periotest™ (Bensheim, Germany) with values of 0 to 9 on
the Periotest scale indicating that the miniscrew is me-
chanically stable and values above 9 indicating clinical
failure, and blunt ends of mouth mirror handles were
used for visual evaluation [13]. A miniscrew was consid-
ered healthy if there was no visible sign of inflammation
with no or physiologic mobility (Periotest value ranging
from 0 to 9). Presence of mobility (visual miniscrew mo-
bility scales 1 to 3, Periotest value more than 9) was con-
sidered the distinguishing feature between mucositis and
peri-implantitis (Table 2).Statistical analysis
Data was analyzed using SPSS version 20 and represented
in median, maximum and minimum. Changes in between
the quadrants were analyzed using the Friedman test
followed by multiple comparisons using Wilcoxon signed-
rank non-parametric test with Bonferroni correction. A p
value <0.05 was taken as statistically significant, and in




The levels of IL-1β at each site were first tabulated and
compared for each quadrant in each patient. The trend
was found to be the same with no statistically significant
difference among the four quadrants. Figure 2 shows the
average taken for all four quadrants of ten patients
followed for 300 days.
IL-1β level at T1 was 266.33 pg/ml which was sig-
nificantly higher as compared to that at baseline (T2) be-
ing 131.95 pg/ml (p = 0.001). The levels rose slightly
to185.76 pg/ml at T3 compared to T2. At T4, the levels
had risen significantly to 273.93 pg/ml (p = 0.001). The
levels reduced to 153.57 pg/ml at T5 (p = 0.014) and fur-
ther to 137.77 pg/ml at T6. The values were statistically
significant till T5, following which the levels further de-
clined but were not statistically significant (Table 3) with
levels falling to 120.01 pg/ml at T9 (p = 0.737).
Three miniscrew sites were reported with mucositis
initially at T2 and one site at T5 (Table 4). Periotest val-
ues for healthy as well as mucositis sites were between 0
and 9, and clinical miniscrew mobility scale was 0 with
no clinically detectable mobility although miniscrews
with mucositis did show variable amount of redness, swel-
ling and/or pain. Peri-implantitis was reported in two sites
in the same patient, the right and left sides of the man-
dible, at 2 weeks after placement, which was excluded
from the study. IL-1β levels at T1 in these two sites were
274.83 and 228.13 pg/ml, respectively (Table 5). At minis-
crew failure, the level of IL-1β rose significantly to 361.63
and 385.35 pg/ml, respectively, as against two stable min-
iscrews in the maxilla in the same patient where the level
Figure 2 Trend of IL-1β levels in PMCF at different time intervals. 1-T1 (4 hours after Implant placement), 2-T2 (Baseline: 3 weeks, just prior to
loading), 3-T3 (Just after loading: 0 day), 4-T4 (At 24 hours after loading: 1 day), 5-T5 (At 21 days), 6-T6 (At 72 days), 7-T7 (At 120 days), 8-T8 (At 180
days) and 9-T9 (At 300 days). The boxes represent the values from the 25th to the 75th percentile. The middle lines represent the medians. The vertical
lines extend from the minimal to the maximal values, exluding the outliers marked with small dark circles.
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pectively, at 2 weeks after placement, from 167.41 and
192.67 pg/ml, respectively, at T1. Two miniscrews with
peri-implantitis had Periotest values of 22 and 29, respect-
ively, and the clinical miniscrew mobility scale was 3 with
mobility evident. Both the sites clinically showed redness
and swelling, but the patient did not complain of pain.
Discussion
Miniscrew success has been recognized as the ability of
screw to sustain anchorage loads during orthodonticTable 3 Level of IL-1β (pg/ml; median) at various time
observations
Median Range p value against T2
T1 266.33 243.27 to 290.58 0.001
T2 (baseline) 131.95 96.17 to 167.65
T3 185.76 138.96 to 246.89 0.001
T4 273.93 222.10 to 297.56 0.001
T5 153.57 114.91 to 215.76 0.015
T6 137.77 110.61 to 169.34 0.391
T7 123.75 98.32 to 174.50 0.881
T8 119.47 106.14 to 150.72 0.794
T9 120.01 96.82 to 145.40 0.737
p value against T2 as baseline.treatment without inflammation and mobility. Various
studies present in the literature attempt to assess the
stability of miniscrews from different perspectives such
as clinical [3,14,15], biomechanical [16-18], histological
[15,19-21], or biochemical. Several biochemical markers
have been associated with inflammation and remodelling
of peri-implant tissue around osseo-integrated dental
implants [20-23], but only few studies were found in the
literature in which biochemical assessments were used
to investigate the stability of miniscrews [7,24-26]. In the
study by Sari and Ucar [7], IL-1β levels in PMCF were
collected only after loading to determine the effects of
mechanical stress on the miniscrews. The mean IL-1β
level in PMCF of healthy miniscrews did not increase
significantly during orthodontic loading. Intachai et al.
[24] assessed medians of chondroitin sulphate levels in
PMCF around ‘immobile’ miniscrews, between the un-
loaded and loaded periods, which were not significantly
different.
In our prospective study, IL-1β levels were observed at
various times, both before and after the loading of min-
iscrew. It was started with the belief that the clinical sta-
bility of the miniscrew must reflect the activity of the
underlying biomarkers.
In the present study, the first PMCF sample was col-
lected 4 h after miniscrew placement, allowing cessa-
tion of bleeding. The early acute inflammatory changes








T1 T2 T3 T4 T5 T6 T7 T8 T9
2 I II, III, IV 104.7 171.1a 206.6a 269.1a 187.6 193 136.6 173.4 132.5
4 II I, III, IV 277.2 110.1 168 193.8 226.6a 233.2a 123 147.3 135.2
8 III I, II, IV 329.9 247.8a 247a 269.1a 242.2 183.7 107.6 113.1 148.6
9 III I, II, IV 322.7 244.8a 301a 338.6a 244.8a 244.8a 197.8a 167.5a 125.7
One mucositis site was found in both quadrants I and II and two in quadrant III. Quadrant I, right maxilla; quadrant II, left maxilla; quadrant III, left mandible;
quadrant IV, right mandible. aPresence of mucositis in the above mentioned quadrants.
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sponse to the cytokine (IL-1β) which begins within 4 to
6 h after injury and lasts for more than 24 h due to the
trauma during the miniscrew placement procedure. Fur-
ther, IL-1 elicits the release of histamine from mast cells
at the site of inflammation which then triggers early vaso-
dilatation and increased vascular permeability [27].
The fall of IL-1β level at T2 was observed at 3 weeks
whereby miniscrew remained unloaded during this period.
This decreased level suggests that at 21 days, there was no
more cellular stress in the absence of load. A slight in-
crease in the IL-1β level after loading can be explained by
the fact that in orthodontics, mechanical stress appears to
evoke biochemical and structural responses in a variety of
cells in vivo and in vitro [28]. Alhashimi et al. [29] showed
that the application of orthodontic force induces de novo
synthesis of proinflammatory cytokines IL-1β and IL-6,
which support the hypothesis that these proinflammatory
cytokines play important roles in bone resorption during
the application of orthodontic force. IL-1 upregulates re-
ceptor activator of nuclear factor κ B ligand (RANKL)
which leads to bone resorption [30]. Further, according to
Kanzaki et al. [31], bone resorption is regulated by cyto-
kines released in response to the orthodontic force.
Although there were two peaks of IL-1β levels during
the study attributed to delayed loading, it was done to
assess the change in IL-1β level around the unloaded
miniscrew apart from observing the effect of loading
on IL-1β levels. A 3-week period before loading wasTable 5 Trend in the levels of IL-1β in pg/ml in a
peri-implantitis patient
Quadrant Observation time
T1 T2 T3 T4 T5 T6
I 167.41 93.71 139.17 284.42 172.05 102.05
II 192.67 103.24 130.17 292.98 191.23 162.88
III 274.84 361.63a Failure
IV 228.13 385.35a
Quadrant I, right maxilla; quadrant II, left maxilla; quadrant III, left mandible;
quadrant IV, right mandible. aPresence of peri-implantitis in the above
mentioned quadrants.selected based on the study which states that loading
during the first 2 weeks of healing time would damage the
stability of the implant-bone fixture [32,33], further em-
phasizing on the loading period of 3 weeks.
Transient elevation of IL-1β 24 h after loading shows
that the cells within the attached gingiva surrounding
the miniscrew produce IL-1β in response to the orthodon-
tic stimulus which can be detected in the PMCF. This level
of IL-1β peaked since during acute inflammation, IL-1β
which is released 1 to 2 h after mechanical stimulus peaks
at 24 to 48 h [27]. Though IL-1β levels rose signifi-
cantly, the miniscrews were stable. Huja et al. [34] also
demonstrated that miniscrews could withstand significantly
greater force levels and when loaded purely in an axial
direction; they observed maximal force loads of 388.3 N.
Over the period, there was a gradual fall in IL-1β levels
at 21 days after loading, and levels declined further over
the 300-day study period reaching the baseline. This could
be explained by the fact that cytokines are involved in ex-
tensive networks that involve synergistic as well as antag-
onistic interactions and exhibit both negative and positive
regulatory effects on various target cells. IL-1 receptor an-
tagonist (IL-1Ra) inhibits IL-1 action by competing with
IL-1 to bind to the IL-1 receptor (IL-1R) [35,36]. This kind
of feedback or negative regulation is likely to modulate the
remodelling process in vivo after a synergistic or an addi-
tive effect because a number of cytokines are simultan-
eously involved in the mechanically activated periodontal
cells. Also, this decrease might be attributed to the adapta-
tion of periodontal tissues to the orthodontic force, and
feedback mechanisms might prevent an excessive increase
in the inflammation mediators, thereby preventing harm-
ful consequences [37].
An important regulatory step in the expression of the
cytokines is gene transcription. Several positive and nega-
tive transcription factors function in a concerted manner
to regulate the transcription of cytokine genes to initiate
immediately on activation and to shut down quickly, even
in the continuous presence of the stimulating agent [38].
IL-1β levels in this study are high as compared to those of
a previous study [7] which could probably be attributed to
racial variation [39].
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weeks after miniscrew placement and in one site 21 days
after loading. This could be due to the poor oral hygiene
at these sites. Plaque around miniscrews acts as a lo-
cal factor for inflammation. Chemoattractant effect of
bacterial lipopolysaccharide present in plaque activates
macrophages and polymorphonuclear leukocytes to pro-
duce inflammatory mediators like TNF-α, IL-1, IL-6 and
other cytokines related to host response and tissue des-
truction [40]. With regular oral hygiene instructions and
professional oral hygiene measures, the peri-miniscrew in-
flammation subsided.
Peri-implantitis was reported in two miniscrews 2
weeks after placement, before loading, both in the man-
dible of the same patient. It suggests that the primary
factor causing miniscrew loss is peri-miniscrew soft tis-
sue inflammation, not the application of orthodontic
force. A further indication that low-magnitude static
forces are not detrimental to miniscrew success was pre-
sented in a study [41], in which miniscrew losses were
attributed to infection and occurred during healing pe-
riods, not after load activation. The levels of IL-1β from
the failed miniscrews were high even at the time of min-
iscrew placement. The elevation of IL-1β levels before
miniscrew failure might be attributed to underlying bone
resorption around the miniscrew, but the sample size of
peri-implantitis is too small to draw conclusions.
Animal and human studies have shown that the levels
of sex steroids, including progesterone and oestradiol,
fluctuate in accordance with oestrous or menstrual cycle.
Osteoclast activity can be inhibited by oestrogen in a dir-
ect or indirect manner, thereby modulating bone resorp-
tion [42]. This aspect is beyond the scope of this study
since it focused on changes in IL-1β levels with time and
also due to the unequal and small sample size with a
male/female ratio of 7:3.
In this study, PMCF sample collection was done 3
weeks after miniscrew placement. The authors believe that
more frequent sample collection could have been done
during this 3-week period and results of this study could
be further confirmed with a larger sample size. Further,
miniscrews were indirectly loaded; thereby, precise load
on miniscrew cannot be calculated. Since IL-1β levels rise
both during inflammation as well as during orthodontic
loading, the IL-1B levels in PMCF may only represent the
release of cytokine as an inflammatory response but may
not represent the bone stress from orthodontic loading
especially at T6 to T9. Thus, alveolar bone remodelling
biomarkers, in addition to inflammatory mediators, are
suggested to be monitored during further investigations.
Conclusions
The changing levels of IL-1β in PMCF over a duration of
300 days are suggestive of the underlying inflammatoryprocess. IL-1β levels in PMCF show a significant rise
during miniscrew insertion and on immediate loading.
The trend of gradually reducing IL-1β levels around
the mini-screw over the period after loading towards
the baseline is suggestive of adaptive bone response
to stimulus.
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